The DIA 2018 Global Annual Meeting brings together thousands of innovators from around the globe.
Maintaining Patient Engagement in the Development of Patient-Reported Outcome (PRO) Measures
Sarah Clifford, PhD, MSc
Senior Principal, Patient-Centered Outcomes
ICON Clinical Research, Inc, United States
This session outlines the key issues in maintaining and maximizing patient engagement at all stages of the development of PRO and ePRO measures, with examples drawn from our experience of developing PRO measures. Recommendations are made regarding the most appropriate qualitative and quantitative approaches and a framework suggested for quantifying the degree of patient engagement during the multiple stages of scale development.
Learning Objective : Recognize the opportunities for patient engagement through all stages of PRO development; Evaluate the degree of meaningful patient engagement in PRO development.
Ways in Which Patient and Caregiver Recorded Outcomes and Assessments Will Affect Regulators, Industry, and Patients and Payers in the Coming Years
Christine McSherry, BSN, RN
Jett Foundation, United States
Patient Affairs Perspective
Michele Rhee, MBA, MPH
Head of Patient Affairs
Enzyvant, United States
Alison M. Skrinar
Executive Director, Clinical Outcomes Research and Evaluation
Ultragenyx Pharmaceutical, United States